David E Kleiner, MD. PhD

Metabolic Dysfunction-associated Steatotic Liver Disease

Shared therapeutic areas:

Bekir Sami Uyanık, MD,

Hisar Hospital Intercontinental

Metabolic Dysfunction-associated Steatotic Liver Disease

Shared therapeutic areas:

Jane Grove, Associate Professor

Nottingham Digestive Diseases Centre & NIHR Nottingham Biomedical Research Centre, Nottingham, University Hospitals NHS Trust and the University of Nottingham, Queens Medical Centre Nottingham, NG7 2UH

Metabolic Dysfunction-associated Steatotic Liver Disease

Shared therapeutic areas:

Stergios A Polyzos, MD, PhD

School of Medicine, Aristotle University of Thessaloniki

Metabolic Dysfunction-associated Steatotic Liver Disease

Shared therapeutic areas:

Jeong Min Lee, MD

Seoul National University Hospital

Metabolic Dysfunction-associated Steatotic Liver Disease

34 trials

Shared therapeutic areas:

Dimitrios G Goulis, MD, PhD

School of Medicine, Aristotle University of Thessaloniki

Metabolic Dysfunction-associated Steatotic Liver Disease

Shared therapeutic areas:

Magdalena Salcedo, MD, PhD

President of the Spanish Society of Liver Transplantation (SETH)

Metabolic Dysfunction-associated Steatotic Liver Disease

Shared therapeutic areas:

Rongfeng Zhu

The 95th Hospital of Putian

Metabolic Dysfunction-associated Steatotic Liver Disease

Shared therapeutic areas:

Kyle D Wood, MD

University of Alabama at Birmingham

Metabolic Dysfunction-associated Steatotic Liver Disease

Shared therapeutic areas:

Chrysi Nalmpantidou, MD

"G. Gennimatas" General Hospital, Thessaloniki, Greece

Metabolic Dysfunction-associated Steatotic Liver Disease

Shared therapeutic areas: